Search research articles
Contact Us
Filters
Showing results (881-890 of 1,095) with videos related to
Page
of 110
Sort By:
European Urology Oncology
|
April 4, 2024
Papillary Renal Cell Carcinoma: Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study
Francesco Massari, Veronica Mollica, Ondrej Fiala, et al.
Clinical Genitourinary Cancer
|
April 14, 2024
Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study
Veronica Mollica, Francesco Massari, Marco Maruzzo, et al.
Genes and Immunity
|
May 1, 2015
Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection
J Ampuero, J A del Campo, L Rojas, et al.
Journal of Hepatology
|
October 28, 2023
Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe
Lesley A Patmore, Kirsi M A van Eekhout, Maria Buti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 1, 2017
Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN)
Anika Wranke, Lourdes M Pinheiro Borzacov, Raymundo Parana, et al.
Gastroenterology
|
July 1, 2018
Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis
Rafael Esteban, Juan A Pineda, Jose Luis Calleja, et al.
Immunotherapy
|
May 16, 2023
Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab
Satoru Taguchi, Taketo Kawai, Sebastiano Buti, et al.
Cancers
|
May 16, 2023
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study
Sara Elena Rebuzzi, Matteo Brunelli, Francesca Galuppini, et al.
JCO Global Oncology
|
July 8, 2025
Geographical Differences in the Management and Outcomes of Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab After Progression on Platinum-Based Chemotherapy: Results From ARON-2 Study
Mimma Rizzo, Andrey Soares, Shilpa Gupta, et al.
Digestive Diseases and Sciences
|
January 13, 2017
Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma
Mar Riveiro-Barciela, David Tabernero, José L Calleja, et al.
Page
of 110
Search research articles
Search
Showing results (881-890 of 1,095) with videos related to
Sort By:
Page
of 110
European Urology Oncology
|
April 4, 2024
Papillary Renal Cell Carcinoma: Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study
Francesco Massari, Veronica Mollica, Ondrej Fiala, et al.
Clinical Genitourinary Cancer
|
April 14, 2024
Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study
Veronica Mollica, Francesco Massari, Marco Maruzzo, et al.
Genes and Immunity
|
May 1, 2015
Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection
J Ampuero, J A del Campo, L Rojas, et al.
Journal of Hepatology
|
October 28, 2023
Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe
Lesley A Patmore, Kirsi M A van Eekhout, Maria Buti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 1, 2017
Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN)
Anika Wranke, Lourdes M Pinheiro Borzacov, Raymundo Parana, et al.
Gastroenterology
|
July 1, 2018
Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis
Rafael Esteban, Juan A Pineda, Jose Luis Calleja, et al.
Immunotherapy
|
May 16, 2023
Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab
Satoru Taguchi, Taketo Kawai, Sebastiano Buti, et al.
Cancers
|
May 16, 2023
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study
Sara Elena Rebuzzi, Matteo Brunelli, Francesca Galuppini, et al.
JCO Global Oncology
|
July 8, 2025
Geographical Differences in the Management and Outcomes of Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab After Progression on Platinum-Based Chemotherapy: Results From ARON-2 Study
Mimma Rizzo, Andrey Soares, Shilpa Gupta, et al.
Digestive Diseases and Sciences
|
January 13, 2017
Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma
Mar Riveiro-Barciela, David Tabernero, José L Calleja, et al.
Page
of 110